| Validation of the mobile application rating scale (MARS) Y Terhorst, P Philippi, LB Sander, D Schultchen, S Paganini, M Bardus, ... Plos one 15 (11), e0241480, 2020 | 192 | 2020 |
| Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 173 | 2019 |
| German mobile apps in rheumatology: review and analysis using the Mobile Application Rating Scale (MARS) J Knitza, K Tascilar, EM Messner, M Meyer, D Vossen, A Pulla, P Bosch, ... JMIR mHealth and uHealth 7 (8), e14991, 2019 | 150 | 2019 |
| Mobile health usage, preferences, barriers, and eHealth literacy in rheumatology: patient survey study J Knitza, D Simon, A Lambrecht, C Raab, K Tascilar, M Hagen, A Kleyer, ... JMIR mHealth and uHealth 8 (8), e19661, 2020 | 136 | 2020 |
| 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases A De Thurah, P Bosch, A Marques, Y Meissner, CB Mukhtyar, J Knitza, ... Annals of the rheumatic diseases 81 (8), 1065-1071, 2022 | 87 | 2022 |
| CD19-targeted CAR T cells in refractory antisynthetase syndrome F Müller, S Boeltz, J Knitza, M Aigner, S Völkl, S Kharboutli, H Reimann, ... The Lancet 401 (10379), 815-818, 2023 | 79 | 2023 |
| Digital rheumatology in the era of COVID-19: results of a national patient and physician survey A Kernder, H Morf, P Klemm, D Vossen, I Haase, J Mucke, M Meyer, ... RMD open 7 (1), e001548, 2021 | 73 | 2021 |
| 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study C Bergmann, JHW Distler, C Treutlein, K Tascilar, AT Müller, A Atzinger, ... The Lancet Rheumatology 3 (3), e185-e194, 2021 | 66 | 2021 |
| CD19 CAR T-cell therapy in autoimmune disease—a case series with follow-up F Müller, J Taubmann, L Bucci, A Wilhelm, C Bergmann, S Völkl, M Aigner, ... New England Journal of Medicine 390 (8), 687-700, 2024 | 56 | 2024 |
| Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease D Simon, K Tascilar, F Fagni, K Schmidt, G Krönke, A Kleyer, A Ramming, ... Annals of the Rheumatic Diseases 81 (7), 1023-1027, 2022 | 53 | 2022 |
| COVID-19 vaccination in autoimmune disease (COVAD) survey protocol P Sen, L Gupta, JB Lilleker, V Aggarwal, S Kardes, M Milchert, T Gheita, ... Rheumatology international 42 (1), 23-29, 2022 | 50 | 2022 |
| Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial J Knitza, J Mohn, C Bergmann, E Kampylafka, M Hagen, D Bohr, H Morf, ... Arthritis Research & Therapy 23, 1-7, 2021 | 49 | 2021 |
| Acceptance of telerheumatology by rheumatologists and general practitioners in Germany: nationwide cross-sectional survey study F Muehlensiepen, J Knitza, W Marquardt, J Engler, A Hueber, M Welcker Journal of medical Internet research 23 (3), e23742, 2021 | 47 | 2021 |
| Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs A Vodencarevic, K Tascilar, F Hartmann, M Reiser, AJ Hueber, J Haschka, ... Arthritis research & therapy 23, 1-8, 2021 | 45 | 2021 |
| Acceptance, usage, and barriers of electronic patient-reported outcomes among German rheumatologists: survey study M Krusche, P Klemm, M Grahammer, J Mucke, D Vossen, A Kleyer, ... JMIR mHealth and uHealth 8 (7), e18117, 2020 | 40 | 2020 |
| Digital health transition in rheumatology: a qualitative study F Muehlensiepen, S Kurkowski, M Krusche, J Mucke, R Prill, M Heinze, ... International Journal of Environmental Research and Public Health 18 (5), 2636, 2021 | 38 | 2021 |
| Use of medical apps and online platforms among German rheumatologists: Results of the 2016 and 2018 DGRh conference surveys and research conducted by rheumadocs J Knitza, D Vossen, I Geffken, M Krusche, M Meyer, P Sewerin, A Kleyer, ... Zeitschrift für Rheumatologie 78, 839-846, 2019 | 36* | 2019 |
| COVAD survey 2 long-term outcomes: unmet need and protocol ZZ Fazal, P Sen, M Joshi, N Ravichandran, JB Lilleker, V Agarwal, ... Rheumatology international 42 (12), 2151-2158, 2022 | 35 | 2022 |
| COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies A Gil‐Vila, N Ravichandran, A Selva‐O'Callaghan, P Sen, A Nune, ... Muscle & nerve 66 (4), 426-437, 2022 | 35 | 2022 |
| Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients—results from a randomized … J Knitza, K Tascilar, N Vuillerme, E Eimer, P Matusewicz, G Corte, ... Arthritis research & therapy 24 (1), 125, 2022 | 33 | 2022 |
